'Antiplatelet therapy' presentation slideshows

Antiplatelet Therapy

Antiplatelet Therapy. Forever Changed And How Do We Live With It?. Michael C. Trotter, M.D., FACS, FACC Greenville, Mississippi. Antiplatelet Therapy. Why should we care? It is where we live and work. Antiplatelet Therapy. How Did we get here? Caprie (Plavix)

1.15k views • 66 slides

BLOOD FORMING AGENTS

BLOOD FORMING AGENTS. Clinical Thrombosis. > 2.5 million cases of deep venous thrombosis (DVT) annually > 600.000 cases of pulmonary embolism (PE) per year > 50.000 deaths per year from PE > 11.000 post surgical PE deaths per year. Anti Platelet Drugs. INHIBITORS OF PLATELET AGGREGATION.

858 views • 65 slides

BLOOD FORMING AGENTS

BLOOD FORMING AGENTS. Clinical Thrombosis. > 2.5 million cases of deep venous thrombosis (DVT) annually > 600.000 cases of pulmonary embolism (PE) per year > 50.000 deaths per year from PE > 11.000 post surgical PE deaths per year. Anti Platelet Drugs. INHIBITORS OF PLATELET AGGREGATION.

940 views • 65 slides

Antiplatelets in cardiac surgery

710 views • 53 slides

DAPT Duration in PCI: The Art of Medicine When the Science Might Not Exist

580 views • 41 slides

Peripheral Arterial Disease - antiplatelet therapy

653 views • 33 slides

Dr. Doni Firman , SpJP (K)

Translating Evidence into Clinical Practice : Role of More Potent Antiplatelet in Acute Coronary Syndrome. Dr. Doni Firman , SpJP (K). CASE 1 . Usia : 63 tahun

520 views • 32 slides

Dr. Doni Firman , SpJP (K)

Translating Evidence into Clinical Practice : Role of More Potent Antiplatelet in Acute Coronary Syndrome. Dr. Doni Firman , SpJP (K). CASE 1. Usia : 63 tahun

760 views • 32 slides

A Look into the Future of Antiplatelet Therapy

A Look into the Future of Antiplatelet Therapy. Robert A. Harrington MD, FACC, FAHA, FSCAI. Richard Sean Stack MD Distinguished Professor Director, Duke Clinical Research Institute Duke University Medical Center. Relationships Relevant to this Presentation.

460 views • 31 slides

Less than helpful therapies

Less than helpful therapies. James (Jim) M Wright, MD, PhD, CRCP(C) Professor Anesthesiology, Pharmacology & Therapeutics and Medicine University of BC. Declaration. Co-Managing Director, Therapeutics Initiative. Editor-in-Chief, Therapeutics Letter.

479 views • 31 slides

Canadian Cardiovascular Society Antiplatelet Guidelines

Canadian Cardiovascular Society Antiplatelet Guidelines. PERIOPERATIVE MANAGEMENT OF ANTIPLATELET THERAPY Working Group: James D. Douketis MD, FRCP(C); A. Graham Turpie MD, FRCP(C). Objectives.

518 views • 22 slides

Sticky Issues with Antiplatelet Therapy

Sticky Issues with Antiplatelet Therapy. Goal.

346 views • 22 slides

The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome. Thank you for taking the pre-assessment. These questions will be repeated at the end of the activity. CHAMPION Trials: Study Designs. CHAMPION Trials Primary End Point and Stent Thrombosis.

397 views • 21 slides

Postoperative Anticoagulation Re-administration A Dilemma to be solved

Postoperative Anticoagulation Re-administration A Dilemma to be solved. Dr. Rania Hassan Dr. Dina ElEbiary. Case.

761 views • 19 slides

PPI and Antiplatelet Therapy Thienopyridines ????????????

PPI and Antiplatelet Therapy Thienopyridines ????????????. ??? Yunsheng Yang M.D.& Ph.D. ??????????? Digestive Disease Center DDC. Chinese PLA General Hospital. Proton Pump Inhibitors on Marketing. Great success to control Acid related diseases in the past 2 decades

716 views • 19 slides

Aggrenox

Aggrenox. Is it as good as the ads?. Multicentre, randomized, double-blind, placebo-controlled trial 6,602 patients randomized within 3 months of qualifying event (TIA or stroke) Treatment and follow-up time: 2 years Visits at 1 month and 3 months, then at 3-month intervals.

595 views • 15 slides

Canadian Cardiovascular Society Antiplatelet Guidelines

Canadian Cardiovascular Society Antiplatelet Guidelines. MANAGEMENT OF ANTIPLATELET THERAPY IN ASSOCIATION WITH MINOR BLEEDING Working Group: James D. Douketis MD, FRCP(C); A. Graham Turpie MD, FRCP(C). Objectives.

389 views • 15 slides

Bern-Rotterdam Registry

Bern-Rotterdam Registry. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.

146 views • 13 slides

The Pennsylvania Academic Detailing Program

188 views • 10 slides

Managing Patients Who Cannot Take Anticoagulants

Managing Patients Who Cannot Take Anticoagulants. Kenneth W. Mahaffey, MD, FACC Professor of Medicine, Cardiology Faculty Associate Director, DCRI Director, DCRI MegaTrials & CEC Duke Clinical Research Institute Durham, NC.

196 views • 10 slides